{
    "xml": "<topic id=\"PHP1065\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/sodium-nitroprusside\" basename=\"sodium-nitroprusside\" title=\"SODIUM NITROPRUSSIDE\">\n<title>SODIUM NITROPRUSSIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_765\" namespace=\"/interactions/list-of-drug-interactions/vasodilator-antihypertensives/sodium-nitroprusside\">Sodium Nitroprusside</xref>\n</p>\n<data name=\"vtmid\">25849001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_785989341\" title=\"Peripheral vasodilators (antihypertensive)\">Peripheral vasodilators (antihypertensive)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP39943\" outputclass=\"indicationsAndDose\" rev=\"1.28\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypertensive emergencies</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 0.5&#8211;1.5&#8239;micrograms/kg/minute, adjusted in steps of 500&#8239;nanograms/kg/minute every 5&#8239;minutes, usual dose 0.5&#8211;8&#8239;micrograms/kg/minute, use lower doses if already receiving other antihypertensives, stop if response unsatisfactory with max. dose in 10 minutes, lower initial dose of 300&#8239;nanograms/kg/minute has been used.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Maintenance of blood pressure at 30&#8211;40% lower than pretreatment diastolic blood pressure</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>20&#8211;400&#8239;micrograms/minute, use lower doses for patients being treated with other antihypertensives.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Controlled hypotension in anaesthesia during surgery</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Up to 1.5&#8239;micrograms/kg/minute.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Heart failure</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8211;15&#8239;micrograms/minute, increased every 5&#8211;10 minutes as necessary; usual dose 10&#8211;200&#8239;micrograms/minute normally for max. 3 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39867\" outputclass=\"unlicensedUse\" rev=\"1.8\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Not licensed for use in the UK.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39991\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Compensatory hypertension</ph>; <ph outputclass=\"contraindication\">Leber&#8217;s optic atrophy</ph>; <ph outputclass=\"contraindication\">severe vitamin B<sub>12</sub> deficiency</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40004\" outputclass=\"cautions\" rev=\"1.5\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Elderly</ph>; <ph outputclass=\"caution\">hyponatraemia</ph>; <ph outputclass=\"caution\">hypothermia</ph>; <ph outputclass=\"caution\">hypothyroidism</ph>; <ph outputclass=\"caution\">impaired cerebral circulation</ph>; <ph outputclass=\"caution\">ischaemic heart disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39932\" outputclass=\"interactions\" rev=\"1.5\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (sodium nitroprusside).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39886\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">acute transient phlebitis</ph>; <ph outputclass=\"sideEffect\">anxiety</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">perspiration</ph>; <ph outputclass=\"sideEffect\">reduced platelet count</ph>; <ph outputclass=\"sideEffect\">retching</ph>; <ph outputclass=\"sideEffect\">retrosternal discomfort</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Side-effects associated with over rapid reduction in blood pressure:</p>\n<p>Headache, dizziness, nausea, retching, abdominal pain, perspiration, palpitation, anxiety, retrosternal discomfort&#8212;reduce infusion rate if any of these side-effects occur.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p outputclass=\"title\"> Cyanide</p>\n<p>Side-effects caused by excessive plasma concentration of the cyanide metabolite include tachycardia, sweating, hyperventilation, arrhythmias, marked metabolic acidosis (discontinue and give antidote).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39919\" outputclass=\"pregnancy\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid prolonged use&#8212;potential for accumulation of cyanide in fetus.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40013\" outputclass=\"breastFeeding\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available.</p>\n<p>Caution advised due to thiocyanate metabolite.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39955\" outputclass=\"hepaticImpairment\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n<p>Avoid in hepatic failure&#8212;cyanide or thiocyanate metabolites may accumulate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39900\" outputclass=\"renalImpairment\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid prolonged use&#8212;cyanide or thiocyanate metabolites may accumulate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39858\" outputclass=\"monitoringRequirements\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor blood pressure (including intra-arterial blood pressure) and blood-cyanide concentration, and if treatment exceeds 3 days, also blood thiocyanate concentration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39871\" outputclass=\"treatmentCessation\" rev=\"1.5\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Treatment cessation</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid sudden withdrawal&#8212;terminate infusion over 15&#8211;30 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40022\" outputclass=\"directionsForAdministration\" rev=\"1.8\" parent=\"/drugs/sodium-nitroprusside\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For <i>continuous intravenous infusion </i> in Glucose 5%, infuse <i>via</i> infusion device to allow precise control. For further details, consult product literature.</p>\n<p>Protect infusion from light.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78099\" namespace=\"/treatment-summaries/hypertension\" title=\"Hypertension\" count=\"1\" rel=\"backlink\">Hypertension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78159\" namespace=\"/treatment-summaries/antihypertensive-drugs\" title=\"Antihypertensive drugs\" count=\"1\" rel=\"backlink\">Antihypertensive drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_765\" namespace=\"/interactions/list-of-drug-interactions/vasodilator-antihypertensives/sodium-nitroprusside\" title=\"Sodium Nitroprusside\" count=\"1\" rel=\"link\">Sodium Nitroprusside</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n</links>\n</topic>",
    "id": "PHP1065",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/sodium-nitroprusside",
    "basename": "sodium-nitroprusside",
    "title": "SODIUM NITROPRUSSIDE",
    "interactants": [
        {
            "id": "bnf_int_765",
            "label": "Sodium Nitroprusside"
        }
    ],
    "vtmid": "25849001",
    "drugClassification": [
        "Peripheral vasodilators (antihypertensive)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Hypertensive emergencies",
                        "html": "Hypertensive emergencies"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 0.5&#8211;1.5 micrograms/kg/minute, adjusted in steps of 500 nanograms/kg/minute every 5 minutes, usual dose 0.5&#8211;8 micrograms/kg/minute, use lower doses if already receiving other antihypertensives, stop if response unsatisfactory with max. dose in 10 minutes, lower initial dose of 300 nanograms/kg/minute has been used.",
                        "html": "<p>Initially 0.5&#8211;1.5&#8239;micrograms/kg/minute, adjusted in steps of 500&#8239;nanograms/kg/minute every 5&#8239;minutes, usual dose 0.5&#8211;8&#8239;micrograms/kg/minute, use lower doses if already receiving other antihypertensives, stop if response unsatisfactory with max. dose in 10 minutes, lower initial dose of 300&#8239;nanograms/kg/minute has been used.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Maintenance of blood pressure at 30&#8211;40% lower than pretreatment diastolic blood pressure",
                        "html": "Maintenance of blood pressure at 30&#8211;40% lower than pretreatment diastolic blood pressure"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "20&#8211;400 micrograms/minute, use lower doses for patients being treated with other antihypertensives.",
                        "html": "<p>20&#8211;400&#8239;micrograms/minute, use lower doses for patients being treated with other antihypertensives.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Controlled hypotension in anaesthesia during surgery",
                        "html": "Controlled hypotension in anaesthesia during surgery"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Up to 1.5 micrograms/kg/minute.",
                        "html": "<p>Up to 1.5&#8239;micrograms/kg/minute.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Heart failure",
                        "html": "Heart failure"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 10&#8211;15 micrograms/minute, increased every 5&#8211;10 minutes as necessary; usual dose 10&#8211;200 micrograms/minute normally for max. 3 days.",
                        "html": "<p>Initially 10&#8211;15&#8239;micrograms/minute, increased every 5&#8211;10 minutes as necessary; usual dose 10&#8211;200&#8239;micrograms/minute normally for max. 3 days.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Not licensed for use in the UK.",
                "html": "<p>Not licensed for use in the UK.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Compensatory hypertension",
                "html": "Compensatory hypertension"
            },
            {
                "type": "contraindications",
                "textContent": "Leber&#8217;s optic atrophy",
                "html": "Leber&#8217;s optic atrophy"
            },
            {
                "type": "contraindications",
                "textContent": "severe vitamin B12 deficiency",
                "html": "severe vitamin B<sub>12</sub> deficiency"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Elderly",
                "html": "Elderly"
            },
            {
                "type": "cautions",
                "textContent": "hyponatraemia",
                "html": "hyponatraemia"
            },
            {
                "type": "cautions",
                "textContent": "hypothermia",
                "html": "hypothermia"
            },
            {
                "type": "cautions",
                "textContent": "hypothyroidism",
                "html": "hypothyroidism"
            },
            {
                "type": "cautions",
                "textContent": "impaired cerebral circulation",
                "html": "impaired cerebral circulation"
            },
            {
                "type": "cautions",
                "textContent": "ischaemic heart disease",
                "html": "ischaemic heart disease"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (sodium nitroprusside).",
                "html": "<p>Appendix 1 (sodium nitroprusside).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "acute transient phlebitis",
                        "html": "acute transient phlebitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anxiety",
                        "html": "anxiety",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "perspiration",
                        "html": "perspiration",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "reduced platelet count",
                        "html": "reduced platelet count",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "retching",
                        "html": "retching",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "retrosternal discomfort",
                        "html": "retrosternal discomfort",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Side-effects associated with over rapid reduction in blood pressure:",
                "textContent": "Headache, dizziness, nausea, retching, abdominal pain, perspiration, palpitation, anxiety, retrosternal discomfort&#8212;reduce infusion rate if any of these side-effects occur.",
                "html": "<p>Headache, dizziness, nausea, retching, abdominal pain, perspiration, palpitation, anxiety, retrosternal discomfort&#8212;reduce infusion rate if any of these side-effects occur.</p>"
            }
        ],
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "title": "Cyanide",
                "textContent": "Side-effects caused by excessive plasma concentration of the cyanide metabolite include tachycardia, sweating, hyperventilation, arrhythmias, marked metabolic acidosis (discontinue and give antidote).",
                "html": "<p>Side-effects caused by excessive plasma concentration of the cyanide metabolite include tachycardia, sweating, hyperventilation, arrhythmias, marked metabolic acidosis (discontinue and give antidote).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid prolonged use&#8212;potential for accumulation of cyanide in fetus.",
                "html": "<p>Avoid prolonged use&#8212;potential for accumulation of cyanide in fetus.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available.\n\nCaution advised due to thiocyanate metabolite.",
                "html": "<p>No information available.</p><p>Caution advised due to thiocyanate metabolite.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.\n\nAvoid in hepatic failure&#8212;cyanide or thiocyanate metabolites may accumulate.",
                "html": "<p>Use with caution.</p><p>Avoid in hepatic failure&#8212;cyanide or thiocyanate metabolites may accumulate.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid prolonged use&#8212;cyanide or thiocyanate metabolites may accumulate.",
                "html": "<p>Avoid prolonged use&#8212;cyanide or thiocyanate metabolites may accumulate.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor blood pressure (including intra-arterial blood pressure) and blood-cyanide concentration, and if treatment exceeds 3 days, also blood thiocyanate concentration.",
                "html": "<p>Monitor blood pressure (including intra-arterial blood pressure) and blood-cyanide concentration, and if treatment exceeds 3 days, also blood thiocyanate concentration.</p>"
            }
        ]
    },
    "treatmentCessation": {
        "treatmentCessation": [
            {
                "type": "treatmentCessation",
                "textContent": "Avoid sudden withdrawal&#8212;terminate infusion over 15&#8211;30 minutes.",
                "html": "<p>Avoid sudden withdrawal&#8212;terminate infusion over 15&#8211;30 minutes.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For continuous intravenous infusion in Glucose 5%, infuse via infusion device to allow precise control. For further details, consult product literature.\n\nProtect infusion from light.",
                "html": "<p>For <i>continuous intravenous infusion </i> in Glucose 5%, infuse <i>via</i> infusion device to allow precise control. For further details, consult product literature.</p><p>Protect infusion from light.</p>"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78099",
                "label": "Hypertension",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78159",
                "label": "Antihypertensive drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_765",
                "label": "Sodium Nitroprusside",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ]
    }
}